Amigo Announces Rebrand as Concurrence to Turn Healthcare Into a System That Learns
Amigo Announces Rebrand as Concurrence to Turn Healthcare Into a System That Learns
PR Newswire
NEW YORK, Sept. 21, 2026
NEW YORK, Sept. 21, 2026 /PRNewswire/ -- Amigo, the platform for deploying clinical AI, today announced its rebrand as Concurrence. The name change reflects the company's expanded mission of building advanced data and AI systems that health systems, biopharma companies, and public health organizations use to converge on the optimal care pathways for every patient.
"Concurrence means agreement in judgment or opinion," said Ali Khokhar, CEO of Concurrence. "What constitutes the best care for a patient is an empirical question that can be answered when everyone has access to the right context."
Concurrence partners with leading institutions to unify their data into a single foundation called the Health World Model, which supplies full patient context to both AI and clinicians. On top of this foundation, AI-powered workflows are deployed across the care journey, scaling the judgment of expert clinicians and enabling patient interactions to be captured at an atomic level of detail across use cases like patient intake, medication management, and clinical decision support.
From that evidence base, the Concurrence platform identifies the optimal paths from intervention to outcome, called Patient Trajectories, to surface what is most likely to work for which patients. These learnings allow health systems to optimize their operational and clinical investments, biopharma companies to improve medication adherence and accelerate R&D, and public health agencies to improve population health outcomes.
"We've long treated healthcare as what happens in a 15-minute visit, but the data that determines how patients actually do largely lives outside that window and never gets captured," said Dr. Jay Shah, Chief Medical Officer of Concurrence and former Chief of Medical Staff at Stanford Health Care. "Concurrence captures that missing context, and the expert judgment behind each decision, so every act of care improves the next one."
About Concurrence
Concurrence (formerly known as Amigo) is the data and AI company creating empirical convergence on what works in healthcare. The company partners with health systems, biopharma companies, and public health agencies to unify their data and deploy AI that learns from every act of care. Enterprise deployment is supported by native integrations with all major EHRs (Epic, Oracle Health, Athenahealth, and more) and full HIPAA, SOC 2 Type II, and GDPR compliance. To date, the Concurrence platform has driven over 10 million patient interactions. For more information, visit www.concurrence.com.
Media Contact:
Kyum Kim
info@concurrence.com
SOURCE Concurrence Inc
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
The 10 Best Companies to Invest in Now
14 Elite Funds and ETFs, and 5 Popular Funds That Just Missed the Mark
4 Stocks to Buy Before They Rise Further
The Top Funds for a Simpler Retirement Portfolio
United States